"Mesonephroma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rare tumor of the female genital tract, most often the ovary, formerly considered to be derived from mesonephric rests. Two varieties are recognized: (1) clear cell carcinoma, so called because of its histologic resemblance to renal cell carcinoma, and now considered to be of muellerian duct derivation and (2) an embryonal tumor (called also ENDODERMAL SINUS TUMOR and yolk sac tumor), occurring chiefly in children. The latter variety may also arise in the testis. (Dorland, 27th ed)
| Descriptor ID |
D008649
|
| MeSH Number(s) |
C04.557.465.510
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mesonephroma".
Below are MeSH descriptors whose meaning is more specific than "Mesonephroma".
This graph shows the total number of publications written about "Mesonephroma" by people in this website by year, and whether "Mesonephroma" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Mesonephroma" by people in Profiles.
-
Lahdenne P, Heikinheimo M, Perkki? M, Rapola J, Miettinen M. Cell differentiation in sacrococcygeal teratomas. An immunohistochemical and follow-up study. Pathol Res Pract. 1990 Jun; 186(3):336-43.
-
Kommoss F, Bibbo M, Talerman A. Nuclear deoxyribonucleic acid content (ploidy) of endodermal sinus (yolk sac) tumor. Lab Invest. 1990 Feb; 62(2):223-31.
-
Miettinen M, Virtanen I, Talerman A. Intermediate filament proteins in human testis and testicular germ-cell tumors. Am J Pathol. 1985 Sep; 120(3):402-10.
-
Amenta PS, Clark CC, Martinez-Hernandez A. Deposition of fibronectin and laminin in the basement membrane of the rat parietal yolk sac: immunohistochemical and biosynthetic studies. J Cell Biol. 1983 Jan; 96(1):104-11.